Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparative Effects of Elliptical Exercises and Swiss Ball Aerobics Exercises in Post CABG Patients

5 de mayo de 2026 actualizado por: Riphah International University

Comparative Effects Of Elliptical Exercises And Swiss Ball Aerobics Exercises On Functional Capacity, Heart Rate, Dyspnea , And Quality Of Life In Post CABG Patients

This randomized controlled trial will compare the effectiveness of elliptical exercise training and Swiss ball exercise therapy in post-CABG patients. A total of 32 participants will be recruited through convenient sampling and randomly allocated into two groups (16 each). Group A will receive supervised elliptical exercise training, while Group B will perform Swiss ball exercises, with sessions conducted three times per week for 6-8 weeks. Outcomes including functional exercise capacity (Six-Minute Walk Test), resting heart rate (pulse oximetry), dyspnea (Modified Borg Scale), and quality of life (SF-36) will be assessed at baseline and post-intervention. Data will be analyzed using SPSS to determine the more effective rehabilitation approach for improving recovery after CABG.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Descripción detallada

Coronary artery bypass grafting (CABG) is a widely performed surgical intervention aimed at restoring adequate myocardial perfusion in patients with severe coronary artery disease. Despite its benefits, patients often experience persistent limitations in functional capacity, elevated resting heart rate, and dyspnea, during the postoperative period. Effective rehabilitation strategies are essential to facilitate recovery and enhance quality of life in this population.

This randomized controlled trial aims to compare the effects of two rehabilitation approaches elliptical exercise training and Swiss ball exercise therapy on key clinical and psychological outcomes in post-CABG patients. Patient of post CABG will be selected by convenient sampling technique 32 Participants will be randomly assigned to either group 16 in each group. Group A will be treated by elliptical exercises and B will be treated with Swiss ball exercises and will engage in supervised exercise sessions three times a week for 6 to 8 weeks. Outcomes including functional exercise capacity (measured via the six-minute walk test), resting heart rate (pulse ox), dyspnea (Modified Borg Scale), and quality of life (SF-36) will be evaluated before and after the intervention.

Data will be analyzed using statistical package for social sciences spss. By comparing these two approaches, this research aims to determine which exercise method is more effective in improving both physical parameters and quality of life in post-CABG patients. The results could help improve rehabilitation programs and support faster, more complete recoveries for heart surgery patients.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

32

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Punjab Province
      • Lahore, Punjab Province, Pakistán, 54000
        • Riphah International University
        • Investigador principal:
          • Khadija Nawaz, MsPT(CPPT)

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

INCLUSION CRITERIA

  • Adult patients aged 40 to 60 years who have undergone elective or scheduled coronary artery bypass grafting (CABG) surgery.
  • Post-operative duration between 2 to 6 weeks, medically cleared to begin rehabilitation exercises.
  • Hemodynamically stable (normal vital signs, no signs of acute cardiac distress).
  • Willing and able to participate in a supervised rehabilitation program.

EXCLUSION CRITERIA

  • Patients with unstable angina, recent myocardial infarction (<2 weeks), or uncontrolled arrhythmias.
  • Patients with severe valvular heart disease or left ventricular ejection fraction <30%.
  • Individuals with neurological conditions (e.g., Parkinson's disease, stroke) that impair mobility or coordination.
  • Patients with severe musculoskeletal disorders (e.g., joint replacement, severe arthritis, recent fractures).
  • Cognitive impairment (e.g., dementia, significant memory loss) that prevents understanding or following instructions.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Group A
Group A will be recieving elliptical exercise (Steady state moderate intensity protocol on elliptical trainer, interval elliptical training)
Participants allocated to the this group will undergo a structured aerobic training program using an elliptical trainer. The exercise prescription will adhere to the FITT framework as follows: frequency of five sessions per week, moderate intensity (targeting approximately 50-70% of heart rate reserve or corresponding Rating of Perceived Exertion of 12-14 on the Borg scale), and duration of 30 minutes per session. Each session will be supervised and will include appropriate warm-up and cool-down periods according to standard cardiac rehabilitation protocols. The intervention will be delivered consistently throughout the study period using an elliptical exercise modality.
Comparador activo: Group B
Group B will be recieving swiss ball exercises (Seated arm raises with light weights and bands, seated torso rotation,seated bouncing,arm circles and punches while sitting,diaphragmatic breathing with ball hug, wall squat with swiss ball support).
Participants allocated to this group will receive a structured exercise program using Swiss ball-based training. The intervention will follow the FITT principle as follows: frequency of five sessions per week, moderate intensity (corresponding to a Rating of Perceived Exertion of 12-14 on the Borg scale), and duration of 30 minutes per session. The exercise type will consist of flexibility and breathing exercises performed with the Swiss ball. Each session will be supervised and will include standardized warm-up and cool-down components in accordance with established rehabilitation protocols. The intervention will be delivered consistently throughout the study period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
functional capacity
Periodo de tiempo: pretreatment, 4th week, 8th week
6-Minute Walk Test (6MWT) is a practical and widely used assessment tool to measure exercise capacity and functional status in individuals with various health conditions. To perform the test, a flat, straight corridor with a measured distance is required. The individual is instructed to walk at their own pace, aiming to cover as much distance as possible within the 6-minute time frame. They can slow down, stop, or rest if needed, but the timer continues to run. The test administrator records the total distance walked, as well as any symptoms, such as shortness of breath or fatigue. The 6MWT is a valuable tool for assessing exercise capacity improvement, as it reflects an individual's ability to perform daily activities and can be used to monitor changes in functional status over time or in response to interventions, such as exercise training or rehabilitation programs. By tracking changes in distance walked, healthcare providers can evaluate the effectiveness of treatment plan.
pretreatment, 4th week, 8th week
Heart rate
Periodo de tiempo: pretreatment, 4th week, 8th week.
A pulse oximeter, often referred to as a pulse ox, is a small, non-invasive medical device that clips onto a fingertip, toe, or earlobe to measure two critical health metrics: oxygen saturation (SpO2) and heart rate. Oxygen saturation indicates the percentage of hemoglobin in the blood that is carrying oxygen, while heart rate measures the number of heart beats per minute (bpm). To use a pulse oximeter for measuring heart rate, simply place the device on the chosen site, ensuring a snug fit, and turn it on. After a few seconds, the device will display both your oxygen saturation level and heart rate. It's essential to remain still during measurement to ensure accuracy, as movement can interfere with the readings. A pulse oximeter is a valuable tool for monitoring heart rate, especially for individuals with heart conditions, respiratory issues, or those engaging in high-altitude activities. By providing quick and reliable readings, it helps users track their heart rate in real-time.
pretreatment, 4th week, 8th week.
Dyspnoea
Periodo de tiempo: pretreatment, 4th week, 8th week
The Modified Borg Scale is a widely used tool to assess the severity of dyspnea (shortness of breath) in patients. It is a simple, self-reported scale that asks patients to rate the intensity of their breathlessness from 0 to 10, with 0 indicating "no breathlessness" and 10 indicating "maximal breathlessness." To use the Modified Borg Scale, patients are asked to select a number that corresponds to the severity of their dyspnea, with descriptors provided for each level of severity, such as "slight" (1-2), "moderate" (3-4), "severe" (5-6), and "very severe" (7-10). This scale helps healthcare providers quantify the impact of dyspnea on patients' daily lives and monitor changes in symptoms over time or in response to treatment. By regularly assessing dyspnea using the Modified Borg Scale, healthcare providers can tailor interventions to meet individual patient needs, evaluate the effectiveness of treatments, and improve patient outcomes.
pretreatment, 4th week, 8th week
Quality of life in post-CABG patients
Periodo de tiempo: pretreatment, 4th week , 8th week
The Short Form 36 (SF-36) is a widely used, multi-dimensional health survey that measures eight domains of health status: physical functioning, bodily pain, general health, vitality, social functioning, emotional functioning, and mental health. It is a self-reported questionnaire that assesses an individual's perceived health and well-being over a specific period, typically the past four weeks. The SF-36 is used in various settings, including clinical trials, health services research, and individual patient assessments, to evaluate the impact of diseases, treatments, and interventions on quality of life. To use the SF-36, patients are asked to complete the questionnaire, which consists of 36 items. The results provide a comprehensive profile of the patient's health status, allowing healthcare providers to identify areas of strength and weakness, monitor changes over time, and make informed decisions about care. The SF-36's scores can also be used to compare the health status of differ
pretreatment, 4th week , 8th week

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Wajeeha Zia, phd, Riphah International University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

10 de mayo de 2026

Finalización primaria (Estimado)

20 de agosto de 2026

Finalización del estudio (Estimado)

20 de agosto de 2026

Fechas de registro del estudio

Enviado por primera vez

5 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

5 de mayo de 2026

Publicado por primera vez (Actual)

11 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

11 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir